[Therapeutic survival beyond 5 years in medically treated primary bronchial cancer. Apropos of 9 cases].
The authors report 9 observations of bronchial carcinoma with a surviving time of 5 years or more. They insist on the various factors on which depends the surviving time: --histology: a differentiated epidermoid epithelioma has better results; --localization of the tumour: cancers of the apex or the trachea have a slow evolution but a very bad prognosis; --therapeutical methods: high energy radiotherapy at curative doses is the best medical treatment of bronchial cancer and chemotherapy is only its complement; --prolonged and regular check ups are a major point in this fighting of cancer. Beyond keeping watch on the general health, it enables early detection and treatment of any evolutive recurrence. Seven of their patients benefited from such repeated treatment.
D000276:Adjuvants, Immunologic; D000367:Age Factors; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000401:mortality / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011879:Radiotherapy Dosage; D012075:Remission, Spontaneous; D012907:Smoking; D014134:Tracheal Neoplasms / Q000628:therapy
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D003037:Cobalt Radioisotopes
Survie thérapeutique au-dela de 5 ans des carcinomes bronchiques primitifs traites médicalement. A propos de 9 observations